Skip to main navigation

Overview
Press Releases
Events & Presentations
Stock
Stock Quote & Chart Historic Price Lookup
Financials
SEC Filings
Governance
Governance Documents Committee Composition
Investor Resources

Events & Presentations

Past Events

MiNK Therapeutics Second Quarter 2022 Financial Results

August 9, 2022 at 11:00 AM EDT

Listen to webcast

BTIG 2022 Biotechnology Conference

August 8 - August 9, 2022

Virtual Annual Shareholders Meeting

June 8, 2022 at 5:00 PM EDT

Listen to webcast

B. Riley Securities 2022 Virtual Oncology Conference

January 27, 2022 at 12:00 PM EST

Listen to webcast

4th Annual Evercore ISI HealthCONx Conference

December 1, 2021 at 8:25 AM EST

Listen to webcast

Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting

November 10 - November 14, 2021

Persistence and tissue distribution of Agent-797 – a native allogeneic iNKT cell-based cell therapy drug product 1 MB

Identification and Characterization of an Allogeneic iNKT-CAR Targeting BCMA 1.5 MB

agenT-797, a native allogeneic “off-the-shelf” iNKT cell therapy product shows anti-tumor activity 1.6 MB